20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
PURE Bioscience (NASDAQ: PURE)today reported product revenues for the fiscal second quarter ended January 31, 2011 of $58,400, compared with product revenues of $327,000 in the same quarter of the prior fiscal year.
The Company reported a net loss of $2,479,600 or $(0.07) per share for the current quarter, compared with a net loss of $1,766,200 or $(0.05) per share in the second fiscal quarter last year. Also during the second quarter of fiscal year 2011, the Company recorded licensing revenue of $10,000.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!